nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepyramine—CYP2D6—breast cancer	0.275	1	CbGaD
Mepyramine—Doxylamine—Toremifene—breast cancer	0.128	0.215	CrCrCtD
Mepyramine—Bromodiphenhydramine—Toremifene—breast cancer	0.108	0.182	CrCrCtD
Mepyramine—Orphenadrine—Toremifene—breast cancer	0.0848	0.143	CrCrCtD
Mepyramine—Doxylamine—Tamoxifen—breast cancer	0.0801	0.135	CrCrCtD
Mepyramine—Tripelennamine—Tamoxifen—breast cancer	0.0725	0.122	CrCrCtD
Mepyramine—Bromodiphenhydramine—Tamoxifen—breast cancer	0.0678	0.114	CrCrCtD
Mepyramine—Orphenadrine—Tamoxifen—breast cancer	0.0532	0.0897	CrCrCtD
Mepyramine—CYP2D6—Idarubicin—breast cancer	0.0245	0.414	CbGbCtD
Mepyramine—CYP2D6—Vinorelbine—breast cancer	0.012	0.202	CbGbCtD
Mepyramine—CYP2D6—Tamoxifen—breast cancer	0.0108	0.183	CbGbCtD
Mepyramine—CYP2D6—Vinblastine—breast cancer	0.00739	0.125	CbGbCtD
Mepyramine—CYP2D6—Doxorubicin—breast cancer	0.00454	0.0766	CbGbCtD
Mepyramine—SLC22A4—mammary gland—breast cancer	0.00155	0.0991	CbGeAlD
Mepyramine—SLC22A5—mammary gland—breast cancer	0.00103	0.0656	CbGeAlD
Mepyramine—Rosiglitazone—SLCO1B1—breast cancer	0.000952	0.269	CrCbGaD
Mepyramine—SLC22A5—nipple—breast cancer	0.000851	0.0543	CbGeAlD
Mepyramine—SLC22A4—endometrium—breast cancer	0.000776	0.0495	CbGeAlD
Mepyramine—HRH1—nipple—breast cancer	0.000722	0.046	CbGeAlD
Mepyramine—SLC22A4—pituitary gland—breast cancer	0.000703	0.0448	CbGeAlD
Mepyramine—SLC22A4—adipose tissue—breast cancer	0.0007	0.0446	CbGeAlD
Mepyramine—SLC22A4—female reproductive system—breast cancer	0.000643	0.041	CbGeAlD
Mepyramine—SLC22A4—adrenal gland—breast cancer	0.000628	0.04	CbGeAlD
Mepyramine—SLC22A4—bone marrow—breast cancer	0.000607	0.0387	CbGeAlD
Mepyramine—SLC22A5—skin of body—breast cancer	0.000545	0.0347	CbGeAlD
Mepyramine—SLC22A5—endometrium—breast cancer	0.000514	0.0328	CbGeAlD
Mepyramine—HRH1—epithelium—breast cancer	0.000486	0.031	CbGeAlD
Mepyramine—SLC22A5—pituitary gland—breast cancer	0.000465	0.0296	CbGeAlD
Mepyramine—SLC22A5—adipose tissue—breast cancer	0.000463	0.0295	CbGeAlD
Mepyramine—HRH1—endometrium—breast cancer	0.000436	0.0278	CbGeAlD
Mepyramine—SLC22A5—female reproductive system—breast cancer	0.000426	0.0271	CbGeAlD
Mepyramine—SLC22A5—adrenal gland—breast cancer	0.000415	0.0265	CbGeAlD
Mepyramine—HRH1—adipose tissue—breast cancer	0.000393	0.025	CbGeAlD
Mepyramine—SLC22A5—female gonad—breast cancer	0.000387	0.0247	CbGeAlD
Mepyramine—SLC22A4—lymph node—breast cancer	0.000376	0.024	CbGeAlD
Mepyramine—HRH1—female reproductive system—breast cancer	0.000361	0.023	CbGeAlD
Mepyramine—Rosiglitazone—PTGS1—breast cancer	0.000355	0.1	CrCbGaD
Mepyramine—HRH1—adrenal gland—breast cancer	0.000352	0.0225	CbGeAlD
Mepyramine—HRH1—female gonad—breast cancer	0.000328	0.0209	CbGeAlD
Mepyramine—HRH1—endocrine gland—breast cancer	0.000305	0.0195	CbGeAlD
Mepyramine—CYP2D6—female reproductive system—breast cancer	0.000275	0.0175	CbGeAlD
Mepyramine—Orphenadrine—SCN10A—breast cancer	0.000269	0.0761	CrCbGaD
Mepyramine—CYP2D6—female gonad—breast cancer	0.00025	0.0159	CbGeAlD
Mepyramine—SLC22A5—lymph node—breast cancer	0.000249	0.0159	CbGeAlD
Mepyramine—Rosiglitazone—CYP2D6—breast cancer	0.000242	0.0682	CrCbGaD
Mepyramine—CYP2D6—endocrine gland—breast cancer	0.000232	0.0148	CbGeAlD
Mepyramine—Tripelennamine—CYP2D6—breast cancer	0.000222	0.0627	CrCbGaD
Mepyramine—HRH1—lymph node—breast cancer	0.000211	0.0135	CbGeAlD
Mepyramine—Rosiglitazone—ALB—breast cancer	0.000181	0.051	CrCbGaD
Mepyramine—Diltiazem—CYP2D6—breast cancer	0.000155	0.0436	CrCbGaD
Mepyramine—Carbinoxamine—CYP2D6—breast cancer	0.000152	0.0428	CrCbGaD
Mepyramine—Diltiazem—CYP3A4—breast cancer	0.000133	0.0374	CrCbGaD
Mepyramine—Brompheniramine—CYP2D6—breast cancer	0.000131	0.0371	CrCbGaD
Mepyramine—Carbinoxamine—CYP3A4—breast cancer	0.00013	0.0367	CrCbGaD
Mepyramine—Chlorphenamine—CYP2D6—breast cancer	0.000129	0.0364	CrCbGaD
Mepyramine—Brompheniramine—CYP3A4—breast cancer	0.000113	0.0318	CrCbGaD
Mepyramine—Chlorphenamine—CYP3A4—breast cancer	0.000111	0.0312	CrCbGaD
Mepyramine—Diltiazem—ABCB1—breast cancer	0.00011	0.0312	CrCbGaD
Mepyramine—Methotrimeprazine—CYP2D6—breast cancer	8.71e-05	0.0246	CrCbGaD
Mepyramine—Orphenadrine—CYP3A4—breast cancer	7.1e-05	0.02	CrCbGaD
Mepyramine—HRH1—Signaling Pathways—SFRP2—breast cancer	2e-05	0.000379	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PRLR—breast cancer	1.96e-05	0.000372	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—CXCR4—breast cancer	1.95e-05	0.000371	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—CXCL12—breast cancer	1.95e-05	0.000371	CbGpPWpGaD
Mepyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—breast cancer	1.95e-05	0.00037	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—SHMT1—breast cancer	1.91e-05	0.000362	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—CDA—breast cancer	1.91e-05	0.000362	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—GLI2—breast cancer	1.89e-05	0.000359	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—VCP—breast cancer	1.89e-05	0.000359	CbGpPWpGaD
Mepyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—breast cancer	1.88e-05	0.000357	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—LEPR—breast cancer	1.86e-05	0.000353	CbGpPWpGaD
Mepyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—breast cancer	1.86e-05	0.000352	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—SLC2A5—breast cancer	1.84e-05	0.000348	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—SLCO1B1—breast cancer	1.84e-05	0.000348	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—CALCA—breast cancer	1.82e-05	0.000345	CbGpPWpGaD
Mepyramine—HRH1—G alpha (q) signalling events—PIK3CA—breast cancer	1.8e-05	0.000342	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—CXCR4—breast cancer	1.77e-05	0.000337	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—CXCL12—breast cancer	1.77e-05	0.000337	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—APRT—breast cancer	1.77e-05	0.000336	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—AGTR1—breast cancer	1.77e-05	0.000335	CbGpPWpGaD
Mepyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—breast cancer	1.75e-05	0.000333	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—ARHGDIA—breast cancer	1.73e-05	0.000328	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—FST—breast cancer	1.69e-05	0.00032	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—ESRRA—breast cancer	1.67e-05	0.000316	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—ANGPTL4—breast cancer	1.67e-05	0.000316	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—HEY2—breast cancer	1.67e-05	0.000316	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—RPS6KB2—breast cancer	1.65e-05	0.000312	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—RGS2—breast cancer	1.63e-05	0.000309	CbGpPWpGaD
Mepyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—breast cancer	1.61e-05	0.000306	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—CCL20—breast cancer	1.61e-05	0.000305	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—AGTR1—breast cancer	1.6e-05	0.000304	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—ITPR1—breast cancer	1.59e-05	0.000301	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—HADHB—breast cancer	1.58e-05	0.0003	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—GPI—breast cancer	1.58e-05	0.0003	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—TLE3—breast cancer	1.56e-05	0.000296	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—LPAR1—breast cancer	1.56e-05	0.000296	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—HEY1—breast cancer	1.54e-05	0.000293	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—DLL1—breast cancer	1.51e-05	0.000287	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—ALDH7A1—breast cancer	1.51e-05	0.000286	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—ALDH1A1—breast cancer	1.51e-05	0.000286	CbGpPWpGaD
Mepyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—breast cancer	1.49e-05	0.000283	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—HIST1H2BK—breast cancer	1.48e-05	0.000282	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—HIST1H2BC—breast cancer	1.48e-05	0.000282	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—GRB7—breast cancer	1.47e-05	0.000279	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PDE4D—breast cancer	1.47e-05	0.000279	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—CSF2—breast cancer	1.46e-05	0.000278	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—NME1—breast cancer	1.45e-05	0.000274	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—FHL2—breast cancer	1.45e-05	0.000274	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—ADSL—breast cancer	1.45e-05	0.000274	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—UMPS—breast cancer	1.45e-05	0.000274	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—PHGDH—breast cancer	1.45e-05	0.000274	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—TAB2—breast cancer	1.45e-05	0.000274	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—ITPR1—breast cancer	1.44e-05	0.000273	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—CNR2—breast cancer	1.43e-05	0.000272	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—CXCL8—breast cancer	1.43e-05	0.000272	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—MMP3—breast cancer	1.43e-05	0.000271	CbGpPWpGaD
Mepyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—breast cancer	1.43e-05	0.000271	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—HPSE—breast cancer	1.42e-05	0.000269	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—LDHB—breast cancer	1.42e-05	0.000269	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—BRIP1—breast cancer	1.42e-05	0.000269	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—DKK1—breast cancer	1.4e-05	0.000265	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—VEGFC—breast cancer	1.39e-05	0.000263	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—JAG2—breast cancer	1.37e-05	0.000259	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—WNT1—breast cancer	1.35e-05	0.000256	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—PLA2G4A—breast cancer	1.34e-05	0.000255	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—HMMR—breast cancer	1.34e-05	0.000255	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—GSTA3—breast cancer	1.34e-05	0.000255	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—ABCC1—breast cancer	1.34e-05	0.000255	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—CSF2—breast cancer	1.33e-05	0.000252	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—PPARGC1B—breast cancer	1.3e-05	0.000247	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—NOTCH4—breast cancer	1.28e-05	0.000242	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—GZMB—breast cancer	1.27e-05	0.000241	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—AGTR2—breast cancer	1.23e-05	0.000234	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—CXCL2—breast cancer	1.23e-05	0.000234	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—GSTA4—breast cancer	1.23e-05	0.000233	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—CA9—breast cancer	1.23e-05	0.000233	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PTHLH—breast cancer	1.22e-05	0.000231	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—BMP2—breast cancer	1.22e-05	0.000231	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—GPX2—breast cancer	1.2e-05	0.000227	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—GSTA2—breast cancer	1.2e-05	0.000227	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—SULT1A1—breast cancer	1.18e-05	0.000224	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—GPX4—breast cancer	1.18e-05	0.000224	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—EDNRB—breast cancer	1.18e-05	0.000224	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PGR—breast cancer	1.17e-05	0.000222	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—THBS1—breast cancer	1.16e-05	0.000221	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—IDH1—breast cancer	1.16e-05	0.000219	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—GSTA1—breast cancer	1.16e-05	0.000219	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—NAT2—breast cancer	1.14e-05	0.000217	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—FLT1—breast cancer	1.11e-05	0.000211	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—FGF3—breast cancer	1.11e-05	0.00021	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—SQSTM1—breast cancer	1.11e-05	0.00021	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—PIK3CG—breast cancer	1.1e-05	0.000209	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—JAG1—breast cancer	1.09e-05	0.000207	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PARP1—breast cancer	1.09e-05	0.000206	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—NOTCH3—breast cancer	1.09e-05	0.000206	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—CALCA—breast cancer	1.07e-05	0.000204	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—RPS6—breast cancer	1.06e-05	0.000201	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—FGF4—breast cancer	1.05e-05	0.0002	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—CXCR4—breast cancer	1.05e-05	0.000199	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—CXCL12—breast cancer	1.05e-05	0.000199	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PAK1—breast cancer	1.03e-05	0.000195	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—TCF7L2—breast cancer	1.01e-05	0.000192	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—AKT2—breast cancer	1.01e-05	0.000191	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—MED12—breast cancer	1e-05	0.00019	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—DPYD—breast cancer	1e-05	0.00019	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—PIK3CG—breast cancer	9.99e-06	0.000189	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—ALDOA—breast cancer	9.87e-06	0.000187	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—HSP90AA1—breast cancer	9.75e-06	0.000185	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—NOTCH2—breast cancer	9.75e-06	0.000185	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—PIK3CD—breast cancer	9.67e-06	0.000183	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—NCOA3—breast cancer	9.58e-06	0.000182	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—SLC2A2—breast cancer	9.51e-06	0.00018	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—AGTR1—breast cancer	9.48e-06	0.00018	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PRL—breast cancer	9.48e-06	0.00018	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—STK11—breast cancer	9.34e-06	0.000177	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—ADAM10—breast cancer	9.34e-06	0.000177	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—MTR—breast cancer	9.32e-06	0.000177	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—ABCG2—breast cancer	9.32e-06	0.000177	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—CPT1A—breast cancer	9.32e-06	0.000177	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PLG—breast cancer	9.24e-06	0.000175	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—HPGDS—breast cancer	9.14e-06	0.000173	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—AKT2—breast cancer	9.14e-06	0.000173	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—FGF10—breast cancer	9.09e-06	0.000172	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—HBA1—breast cancer	9.08e-06	0.000172	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—GSTT1—breast cancer	8.86e-06	0.000168	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—ACHE—breast cancer	8.86e-06	0.000168	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—PIK3CD—breast cancer	8.78e-06	0.000167	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PDGFA—breast cancer	8.77e-06	0.000166	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—TGFBR2—breast cancer	8.65e-06	0.000164	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—ITPR1—breast cancer	8.51e-06	0.000161	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—STAT5A—breast cancer	8.45e-06	0.00016	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—MMP3—breast cancer	8.45e-06	0.00016	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—ERBB4—breast cancer	8.45e-06	0.00016	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—PIK3CB—breast cancer	8.43e-06	0.00016	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—CYP17A1—breast cancer	8.39e-06	0.000159	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—ENO1—breast cancer	8.3e-06	0.000158	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—PTGS1—breast cancer	8.3e-06	0.000158	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—SMAD4—breast cancer	8.18e-06	0.000155	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—IGF1R—breast cancer	8.13e-06	0.000154	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—CXCL8—breast cancer	8.1e-06	0.000154	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—NCOA2—breast cancer	7.99e-06	0.000152	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—HES1—breast cancer	7.99e-06	0.000152	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PLA2G4A—breast cancer	7.94e-06	0.000151	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—NCOR1—breast cancer	7.94e-06	0.000151	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—CSF2—breast cancer	7.86e-06	0.000149	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—FGF1—breast cancer	7.86e-06	0.000149	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—RAF1—breast cancer	7.84e-06	0.000149	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—NRG1—breast cancer	7.8e-06	0.000148	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—FASN—breast cancer	7.75e-06	0.000147	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—H2AFX—breast cancer	7.74e-06	0.000147	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—IL2—breast cancer	7.74e-06	0.000147	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—BCHE—breast cancer	7.72e-06	0.000146	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—E2F1—breast cancer	7.69e-06	0.000146	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—PIK3CB—breast cancer	7.65e-06	0.000145	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—SLC5A5—breast cancer	7.63e-06	0.000145	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—SPP1—breast cancer	7.39e-06	0.00014	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—SLC2A1—breast cancer	7.36e-06	0.00014	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—NQO1—breast cancer	7.36e-06	0.00014	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—CXCL8—breast cancer	7.35e-06	0.000139	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—ERBB3—breast cancer	7.31e-06	0.000139	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—FGFR2—breast cancer	7.29e-06	0.000138	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—CYP3A4—breast cancer	7.18e-06	0.000136	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—CYP1B1—breast cancer	7.06e-06	0.000134	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—IL2—breast cancer	7.03e-06	0.000133	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—TERT—breast cancer	7e-06	0.000133	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—HSP90AA1—breast cancer	6.92e-06	0.000131	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—FGFR1—breast cancer	6.8e-06	0.000129	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—NCOA1—breast cancer	6.74e-06	0.000128	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—HIF1A—breast cancer	6.7e-06	0.000127	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—STK11—breast cancer	6.64e-06	0.000126	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—CYP19A1—breast cancer	6.64e-06	0.000126	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—LEP—breast cancer	6.54e-06	0.000124	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—CAV1—breast cancer	6.48e-06	0.000123	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—KDR—breast cancer	6.4e-06	0.000121	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—ESR1—breast cancer	6.24e-06	0.000118	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—COMT—breast cancer	6.17e-06	0.000117	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—FN1—breast cancer	6.16e-06	0.000117	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—GSTP1—breast cancer	6.14e-06	0.000117	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—NFKBIA—breast cancer	6.09e-06	0.000116	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—HMOX1—breast cancer	6.06e-06	0.000115	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—ITPR1—breast cancer	6.04e-06	0.000115	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—NOTCH1—breast cancer	6.03e-06	0.000114	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PIK3CG—breast cancer	5.9e-06	0.000112	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—APC—breast cancer	5.9e-06	0.000112	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—KIT—breast cancer	5.9e-06	0.000112	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—EGF—breast cancer	5.83e-06	0.000111	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—ABCB1—breast cancer	5.81e-06	0.00011	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—TYMS—breast cancer	5.71e-06	0.000108	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—MAPK3—breast cancer	5.65e-06	0.000107	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—PLA2G4A—breast cancer	5.64e-06	0.000107	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—NCOR1—breast cancer	5.64e-06	0.000107	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—GSTM1—breast cancer	5.64e-06	0.000107	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—BRAF—breast cancer	5.55e-06	0.000105	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—GPX1—breast cancer	5.41e-06	0.000103	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—IGF1—breast cancer	5.4e-06	0.000102	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—AKT2—breast cancer	5.4e-06	0.000102	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—EGFR—breast cancer	5.37e-06	0.000102	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—CYP1A1—breast cancer	5.35e-06	0.000102	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—ERCC2—breast cancer	5.31e-06	0.000101	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PIK3CD—breast cancer	5.19e-06	9.84e-05	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—PIK3CA—breast cancer	5.14e-06	9.74e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—SERPINE1—breast cancer	5.13e-06	9.73e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—KRAS—breast cancer	5.08e-06	9.63e-05	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—MTHFR—breast cancer	4.99e-06	9.46e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—NOS3—breast cancer	4.9e-06	9.29e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—PIK3CA—breast cancer	4.66e-06	8.85e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—MDM2—breast cancer	4.65e-06	8.81e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—RAF1—breast cancer	4.63e-06	8.78e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—RELA—breast cancer	4.61e-06	8.74e-05	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—CAV1—breast cancer	4.6e-06	8.73e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—ERBB2—breast cancer	4.58e-06	8.69e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—MTOR—breast cancer	4.52e-06	8.57e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PIK3CB—breast cancer	4.52e-06	8.57e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—CXCL8—breast cancer	4.34e-06	8.24e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—HRAS—breast cancer	4.32e-06	8.19e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—CDKN1B—breast cancer	4.24e-06	8.05e-05	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—AKT1—breast cancer	4.2e-06	7.96e-05	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—PIK3CG—breast cancer	4.19e-06	7.95e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—CASP3—breast cancer	4.16e-06	7.89e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—IL2—breast cancer	4.15e-06	7.87e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—IL6—breast cancer	4.13e-06	7.84e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—CCND1—breast cancer	4.05e-06	7.68e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—JUN—breast cancer	4.04e-06	7.66e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—CTNNB1—breast cancer	4.01e-06	7.6e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—MMP9—breast cancer	3.93e-06	7.45e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—CDKN1A—breast cancer	3.91e-06	7.43e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PTEN—breast cancer	3.91e-06	7.41e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—MAPK8—breast cancer	3.82e-06	7.25e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—AKT1—breast cancer	3.81e-06	7.23e-05	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—PIK3CD—breast cancer	3.68e-06	6.99e-05	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—ALB—breast cancer	3.64e-06	6.9e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—SRC—breast cancer	3.62e-06	6.87e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—VEGFA—breast cancer	3.53e-06	6.69e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—STAT3—breast cancer	3.49e-06	6.63e-05	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—NOS3—breast cancer	3.48e-06	6.6e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—MAPK3—breast cancer	3.34e-06	6.33e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—MYC—breast cancer	3.25e-06	6.16e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—TGFB1—breast cancer	3.24e-06	6.14e-05	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—PIK3CB—breast cancer	3.21e-06	6.09e-05	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—PTGS2—breast cancer	3.18e-06	6.04e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—EGFR—breast cancer	3.17e-06	6.02e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—KRAS—breast cancer	3e-06	5.69e-05	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—PTEN—breast cancer	2.78e-06	5.26e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PIK3CA—breast cancer	2.76e-06	5.23e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—TP53—breast cancer	2.67e-06	5.06e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—HRAS—breast cancer	2.55e-06	4.84e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—IL6—breast cancer	2.44e-06	4.63e-05	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—AKT1—breast cancer	2.25e-06	4.27e-05	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—PIK3CA—breast cancer	1.96e-06	3.71e-05	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—AKT1—breast cancer	1.6e-06	3.03e-05	CbGpPWpGaD
